CYP2D6 genotype test results help physicians to tailor
WILLOW GROVE, Pa.--(BUSINESS WIRE)--
NMS Labs now offers a genotype
test to determine metabolizer status for tramadol, oxycodone and
codeine. This test can aid physicians in guiding the use of these
medications in an effective and safe manner.
Recommended by the FDA for several popular drugs, genotype testing
supports patients and physicians by helping to identify abnormal
metabolism before any drugs are given1. Clinical guidelines
have been established for these drugs based on metabolizer status.
Knowing a patient’s genotype empowers physicians to apply these
guidelines for each individual patient.
Robert Middleberg, NMS Labs Laboratory Director, comments, “NMS Labs
provides reports that translate the metabolizer status into real world
applications, by explaining what type of metabolizer the patient is for
the drug of interest and by offering potential treatment options within
the report. Of course, all final medical decisions related to these
findings belong to the treating physician who can consider these results
in their patient care. Our reports are user-friendly since test results
have little value if they cannot be interpreted into action.”
NMS Labs offers accompanying therapeutic drug monitoring (TDM) of these
same agents to further assist in overall patient response and safety.
NMS Labs is proud to offer these key testing options as part of a
genomic medicine approach to individualized patient-centered treatment.
This test is certified for use in New York State and is FDA-cleared.
About NMS Labs:
NMS Labs is an international forensic and clinical reference laboratory
that is unsurpassed in its scope of toxicology tests, accuracy of
results, scientific expertise, and innovation. The state-of-the-art
headquarters includes clinical, forensic and research facilities, a
dedicated and secure crime laboratory, and is staffed by more than
200 highly trained professionals. NMS Labs is passionate about promoting
public health and safety.
1Dean L. Codeine Therapy and CYP2D6 Genotype. 2012 Sep 20
[Updated 2013 Mar 18]. In: Medical Genetics Summaries [Internet].
Bethesda (MD): National Center for Biotechnology Information (US);
2012-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK100662/
Katherine Friedman, Marketing, 215-366-1756
Source: NMS Labs